NeuroSearch A/S will bank as much as €32 million (US$45.1 million) in guaranteed funding over the next three years on the strength of a new drug discovery and development alliance in central nervous system disease with Janssen Pharmaceutica NV, a subsidiary of Johnson & Johnson Co., of New Brunswick, N.J. (BioWorld International) 

Almost a full year after Pfizer Inc. decided to discontinue development of PF-03187207, it finally handed the compound back to its erstwhile partner, NiCox SA, and has withdrawn from its strategic alliance in ophthalmology with the company. (BioWorld International)